| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Molecular and Cellular Biology, June 2007, p. 3920-3935, Vol. 27, No. 11
0270-7306/07/$08.00+0 doi:10.1128/MCB.01219-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
B Blocks Cytotoxicity Induced by Chemotherapeutic Drugs
James R. Knabb,2
Salvatore Papa,2
Christian Kuntzen,2 and
Guido Franzoso2*
Department of Pathology,1 The Ben May Institute for Cancer Research, The University of Chicago, 924 East 57th Street, Chicago, Illinois 606372
Received 6 July 2006/ Returned for modification 5 September 2006/ Accepted 19 February 2007
NF-
B/Rel transcription factors are central to controlling programmed cell death (PCD). Activation of NF-
B blocks PCD induced by numerous triggers, including ligand engagement of tumor necrosis factor receptor (TNF-R) family receptors. The protective activity of NF-
B is also crucial for oncogenesis and cancer chemoresistance. Downstream of TNF-Rs, this activity of NF-
B has been linked to the suppression of reactive oxygen species and the c-Jun-N-terminal-kinase (JNK) cascade. The mechanism by which NF-
B inhibits PCD triggered by chemotherapeutic drugs, however, remains poorly understood. To understand this mechanism, we sought to identify unrecognized protective genes that are regulated by NF-
B. Using an unbiased screen, we identified the basic-helix-loop-helix factor Twist-1 as a new mediator of the protective function of NF-
B. Twist-1 is an evolutionarily conserved target of NF-
B, blocks PCD induced by chemotherapeutic drugs and TNF-
in NF-
B-deficient cells, and is essential to counter this PCD in cancer cells. The protective activity of Twist-1 seemingly halts PCD independently of interference with cytotoxic JNK, p53, and p19ARF signaling, suggesting that it mediates a novel protective mechanism activated by NF-
B. Indeed, our data indicate that this activity involves a control of inhibitory Bcl-2 phosphorylation. The data also suggest that Twist-1 and -2 play an important role in NF-
B-dependent chemoresistance.
Published ahead of print on 2 April 2007.
Present address: Department of Experimental Medicine, The University of L'Aquila, Via Vetoio-Coppito 2, 67100 L'Aquila, Italy.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|